Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and OutcomesJakub Dobruch, Stephen A. Boorjian, Siamak Daneshmand et al.|European Urology|2015Cited by 688
Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomyAidan P. Noon, Mark T. Boyd, Howida Shawki et al.|British Journal of Urology|2011Cited by 35